Cohort Highlights
>15 Autoimmunte Results
Agents included: >15 autoimmune lab results including antinuclear antibody (ANA) tests, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and more
>28,000 Cohort
Cohort Size: >28K consented Autoimmune disease patients including RA, Lupus, MS, Psoriasis, Hashimoto’s and many more
~ 15yrs lookback
Average patient EHR history: ~15yrs lookback including diagnoses, lab results, prescriptions and much more
Longitudinal Clinical Insights
% of Patients by Age Range
Wide range of adult and geriatric patients across all ages diagnosed with autoimmune conditions with years of look back
% of patients with "X" number of measurements
Longitudinal clinical insights with multiple measurements for key lab results including ESR, CRP and Rheumatoid Factor and many more giving a comprehensive clinical journey
Research Insights
Inflammatory Bowel Disease (IBD), including Crohn’s disease and Ulcerative Colitis impacts millions of people in the US. Conventional treatments are currently limited to reducing inflammation, however personalized treatment can offer options to treat the disease directly. Using data from the Helix Research Network, Helix scientists recently presented an analysis at the ASHG conference on the genetics of Crohn’s disease, and in particular the NOD2 gene where mutations in the gene have been associated with Crohn’s disease and other conditions.
